Santaris Pharma
Edit Page
Report
Scan day: 04 March 2014 UTC
12
Virus safety - good
Description: Developing assays for disease-related microRNAs as therapeutic targets using miRNA antagonists technology.
Santaris’ RNA-targeted therapeutics represent the future of innovation in medicine. is pioneering a new era of antisense therapeutics leveraging our Locked Nucleic Acid (LNA) chemistry platform and tissue targeting expertise. We are developing a diverse pipeline of drug candidates that act selectively on disease-related RNAs to provide patients with novel treatments for both rare and common diseases. Our leadership in innovation and passion for the future of RNA therapeutics has attracted multiple large-scale partnerships and yielded exciting and unique LNA-based drugs.
Size: 578 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Home | Santaris |
| Keywords: | |
| Description: | Santaris Pharma A/S is an international clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. |
| IP-address: | 198.57.169.145 |
WHOIS Info
| NS | Name Server: A.NS.WSMS.DK Name Server: B.NS.WSMS.DK |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 28-feb-2003 Expiration Date: 28-feb-2020 |